Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Digital Healthcare Supply Chain Management Market Size, Share, Trends, and Forecast, 2026-2033 | Cloud-based AI and Digital Twins Drive 8.4% CAGR to $6.7 Billion

globenewswire.com

Global Digital Healthcare Supply Chain Management Market Size, Share, Trends, and Forecast, 2026-2033 | Cloud-based AI and Digital Twins Drive 8.4% CAGR to $6.7 Billion Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Digital Healthcare Supply Chain Management Market Size, Share & Trends Analysis Report by Product, Deployment, End Use, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global digital healthcare supply chain management market was valued at an estimated USD 3.5 billion in 2025 and is projected to reach USD 6.7 billion by 2033. The market is expected to expand at a compound annual growth rate of 8.4% from 2026 to 2033, supported by healthcare digitalization, greater supply chain complexity, and growing demand for operational visibility.

Investment in next-generation technologies, including control towers and digital twin technology, is accelerating across healthcare and life sciences organizations. These capabilities help manufacturers, suppliers, and healthcare providers strengthen supply chain planning, analytics, execution, and risk management. The adoption of integrated dashboards is also increasing as organizations seek timely information about inventory, suppliers, logistics, and product availability.

Cloud-based supply chain management solutions are expected to be a significant market growth driver over the forecast period. Healthcare organizations are implementing cloud platforms to improve supplier quality, inventory optimization, traceability, and coordination across geographically distributed operations. Integration with enterprise resource planning and electronic medical record systems can further reduce the financial and operational effects of supply variability, stockouts, excess inventory, and disconnected workflows.

In January 2026, SAP SE expanded its cloud-based supply chain offerings by adding advanced artificial intelligence and analytics capabilities to its Business Network platform. The enhancements support real-time tracking, stronger traceability, and improved risk management across global supply networks. Developments of this kind demonstrate how cloud-enabled technologies can increase transparency while helping organizations address counterfeit drugs, product recalls, regulatory requirements, and supply disruptions.

The pharmaceutical industry's efforts to limit large-scale drug counterfeiting are also contributing to demand for digital healthcare supply chain management technologies. Enhanced monitoring and product traceability can help organizations protect supply chain integrity, improve recall readiness, and maintain product quality from manufacturing through distribution. Government initiatives designed to strengthen access to medical supplies are expected to provide additional market opportunities.

Rising transportation, production, manufacturing, and inventory storage costs are increasing pressure on healthcare facilities and life sciences companies to improve supply chain performance. Poor inventory control can lead to avoidable spending, expired products, excess stock, and shortages of critical supplies. A study published by NCBI in December 2022 reported that U.S. hospitals waste USD 25.4 billion annually through unnecessary supply chain spending. In response, organizations are adopting inventory management software, Kanban systems, and industrialized barcode terminals to improve control and reduce losses.

Market Segmentation

The report provides global, regional, and country-level revenue forecasts and analyzes industry trends across sub-segments from 2021 to 2033. The market is assessed by product, deployment, end use, and region.

Country-level coverage includes the U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Norway, Denmark, Sweden, Japan, China, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, and Kuwait.

Strategic Value of the Report

The report enables healthcare providers, pharmaceutical companies, medical device manufacturers, biotechnology organizations, technology vendors, and investors to evaluate market opportunities and identify the factors shaping future demand. Its analysis supports strategic decision-making in areas such as cloud adoption, inventory optimization, supplier management, traceability, regulatory compliance, and supply chain resilience.

Key Attributes

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/bixesl

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.